Santhera's Shareholders Approve all Board Proposals at Today's Annual General Meeting [Yahoo! Finance]
Catalyst Pharmaceuticals, Inc. (CPRX)
Last catalyst pharmaceuticals, inc. earnings: 3/16 05:26 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.catalystpharma.com
Company Research
Source: Yahoo! Finance
Directors at the Annual General Meeting (AGM) held today in Pratteln, Switzerland, with a large majority. Participating shareholders represented a total of 4,535,785 shares or 35.9% of the Company's share capital. Approval of the 2023 Annual Report and discharge of corporate bodies The shareholders approved the Annual Report, the annual financial statements and the consolidated financial statements for 2023, as well as the appropriation of the annual result and its offset against free reserves. Furthermore, the shareholders granted discharge to the members of the Board of Directors and Executive Management for the financial year 2023. Approval of amendments to the Articles of Incorporation In four separate votes, the shareholders approved various amendments to the Articles of Incorporation to bring them in line with the revised Swiss corporate law, which came into force on January 1, 2023. The revision of corporate law aimed, among other things, to improve corporate governance
Show less
Read more
Impact Snapshot
Event Time:
CPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CPRX alerts
High impacting Catalyst Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
CPRX
News
- Santhera Secures up to CHF 69 million in Royalty and Debt Financing to Fund Operations to Cash Flow Break-Even [Yahoo! Finance]Yahoo! Finance
- Santhera Announces Launch of Early Access Program in China for AGAMREE® by its Partner Sperogenix [Yahoo! Finance]Yahoo! Finance
- Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- Why Is Catalyst (CPRX) Up 0.7% Since Last Earnings Report? [Yahoo! Finance]Yahoo! Finance
- Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Been Rising: Are Strong Financials Guiding The Market? [Yahoo! Finance]Yahoo! Finance
CPRX
Earnings
- 5/8/24 - Beat
CPRX
Sec Filings
- 6/11/24 - Form 4
- 6/7/24 - Form 4
- 6/7/24 - Form 144
- CPRX's page on the SEC website